1. Home
  2. SLE vs CPHI Comparison

SLE vs CPHI Comparison

Compare SLE & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLE
  • CPHI
  • Stock Information
  • Founded
  • SLE 2014
  • CPHI N/A
  • Country
  • SLE United States
  • CPHI China
  • Employees
  • SLE N/A
  • CPHI N/A
  • Industry
  • SLE Services-Misc. Amusement & Recreation
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SLE Consumer Discretionary
  • CPHI Health Care
  • Exchange
  • SLE Nasdaq
  • CPHI Nasdaq
  • Market Cap
  • SLE 6.5M
  • CPHI 7.3M
  • IPO Year
  • SLE 2019
  • CPHI N/A
  • Fundamental
  • Price
  • SLE $5.06
  • CPHI N/A
  • Analyst Decision
  • SLE Strong Buy
  • CPHI
  • Analyst Count
  • SLE 2
  • CPHI 0
  • Target Price
  • SLE $100.00
  • CPHI N/A
  • AVG Volume (30 Days)
  • SLE 155.6K
  • CPHI 158.3K
  • Earning Date
  • SLE 08-13-2025
  • CPHI 08-13-2025
  • Dividend Yield
  • SLE N/A
  • CPHI N/A
  • EPS Growth
  • SLE N/A
  • CPHI N/A
  • EPS
  • SLE N/A
  • CPHI N/A
  • Revenue
  • SLE $14,691,000.00
  • CPHI $4,295,377.00
  • Revenue This Year
  • SLE N/A
  • CPHI N/A
  • Revenue Next Year
  • SLE $30.36
  • CPHI N/A
  • P/E Ratio
  • SLE N/A
  • CPHI N/A
  • Revenue Growth
  • SLE N/A
  • CPHI N/A
  • 52 Week Low
  • SLE $3.91
  • CPHI $1.20
  • 52 Week High
  • SLE $65.60
  • CPHI $3.35
  • Technical
  • Relative Strength Index (RSI)
  • SLE 44.57
  • CPHI 52.73
  • Support Level
  • SLE $4.26
  • CPHI $1.70
  • Resistance Level
  • SLE $5.53
  • CPHI $1.91
  • Average True Range (ATR)
  • SLE 0.51
  • CPHI 0.18
  • MACD
  • SLE 0.26
  • CPHI 0.03
  • Stochastic Oscillator
  • SLE 71.21
  • CPHI 59.62

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: